Hope for Alzheimer's? FDA approves Eli Lilly's groundbreaking treatment
Lilly’s drug Kisunla aims to slow the progression of the disease in its early stages. "This is real progress. Today's ...
Lilly’s drug Kisunla aims to slow the progression of the disease in its early stages. "This is real progress. Today's ...
Professor Illana Gozes, Professor Victor OK Li and Dr. Jacqueline CK Lam have created an artificial intelligence-led strategy that helps ...
Researchers target the core pathology responsible for the advancement of the disease, rather than the symptoms alone. Patients show substantial ...
Findings show that patients with Alzheimer's disease and other brain conditions display nonconvulsive epileptic seizure-like activity that can be detected ...
The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.
All rights reserved to Israel Hayom
Hosted by sPD.co.il
[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]